FDA Approves Revolutionary Therapy for Pancreatic Cancer

The U.S. Food and Drug Administration has granted approval for a groundbreaking treatment that nearly doubled overall survival time in clinical trials for pancreatic cancer patients.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

n1-serbiaSerbian3d ago

FDA odobrila revolucionarnu terapiju za kancer pankreasa

Američka Uprava za hranu i lekove (FDA) odobrila je terapiju za kancer pankreasa koja je u kliničkim ispitivanjima gotovo udvostručila ukupno vreme pr

Read full article →

FDA Approves Revolutionary Therapy for Pancreatic Cancer

Sources

FDA odobrila revolucionarnu terapiju za kancer pankreasa

Related Stories

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases

England Pharmacies to Offer Free Quick Cholesterol Screening Tests